ApoE3 Anchored Liposomal Delivery of Rivastigmine for Brain Delivery: Formulation, Characterization, and In Vivo Pharmacokinetic Evaluation
Tóm tắt
Từ khóa
Tài liệu tham khảo
Vaz M, Silvestre S. Alzheimer’s disease: recent treatment strategies. Eur J Pharmacol. 2020;887:173554.
International AD, University M. World Alzheimer Report 2021: Journey through the diagnosis of dementia [Internet]. 2021 [cited 2023 Jun 18]. Available from: https://www.alzint.org/resource/world-alzheimer-report-2021/.
Ashrafian H, Zadeh EH, Khan RH. Review on Alzheimer’s disease: inhibition of amyloid beta and tau tangle formation. Int J Biol Macromol. 2021;167:382–94.
Shamsi TN, Athar T, Parveen R, Fatima S. A review on protein misfolding, aggregation and strategies to prevent related ailments. Int J Biol Macromol. 2017;105:993–1000.
Ullah R, Park TJ, Huang X, Kim MO. Abnormal amyloid beta metabolism in systemic abnormalities and Alzheimer’s pathology: insights and therapeutic approaches from periphery. Ageing Res Rev. 2021;71:101451.
Boche D, Nicoll JAR. Invited Review – Understanding cause and effect in Alzheimer’s pathophysiology: implications for clinical trials. Neuropathol Appl Neurobiol. 2020;46:623–40.
Agatonovic-Kustrin S, Kettle C, Morton DW. A molecular approach in drug development for Alzheimer’s disease. Biomed Pharmacother. 2018;106:553–65.
Marucci G, Buccioni M, Ben DD, Lambertucci C, Volpini R, Amenta F. Efficacy of acetylcholinesterase inhibitors in Alzheimer’s disease. Neuropharmacology. 2021;190:108352.
Nguyen TT, Nguyen TTD, Nguyen TKO, Vo TK, Vo VG. Advances in developing therapeutic strategies for Alzheimer’s disease. Biomed Pharmacother. 2021;139:111623.
Guimarães D, Cavaco-Paulo A, Nogueira E. Design of liposomes as drug delivery system for therapeutic applications. Int J Pharm. 2021;601:120571.
Li M, Du C, Guo N, Teng Y, Meng X, Sun H, et al. Composition design and medical application of liposomes. Eur J Med Chem. 2019;164:640–53.
Gajbhiye KR, Pawar A, Mahadik KR, Gajbhiye V. PEGylated nanocarriers: a promising tool for targeted delivery to the brain. Colloids Surf B Biointerfaces. 2020;187:110770.
Pandian SRK, Vijayakumar KK, Murugesan S, Kunjiappan S. Liposomes: an emerging carrier for targeting Alzheimer’s and Parkinson’s diseases. Heliyon. 2022;8:e09575.
Large DE, Abdelmessih RG, Fink EA, Auguste DT. Liposome composition in drug delivery design, synthesis, characterization, and clinical application. Adv Drug Deliv Rev. 2021;176:113851.
Song Q, Huang M, Yao L, Wang X, Gu X, Chen J, et al. Lipoprotein-based nanoparticles rescue the memory loss of mice with Alzheimer’s disease by accelerating the clearance of amyloid-beta. ACS Nano [Internet]. 2014 [cited 2023 Jun 18];8:2345–59. Available from: https://pubs.acs.org/doi/full/10.1021/nn4058215.
Aleshkov S, Abraham CR, Zannis VI. Interaction of nascent apoe2, apoe3, and apoe4 isoforms expressed in mammalian cells with amyloid peptide β (1-40). Relevance to Alzheimer’s disease. Biochemistry [Internet]. 1997 [cited 2023 Jun 18];36:10571–80. Available from: https://pubs.acs.org/doi/full/10.1021/bi9626362.
Nguyen K, Hoffman H, Chakkamparambil B, Grossberg GT. Evaluation of rivastigmine in Alzheimer’s disease. Neurodegener Dis Manag. 2020;11:35–48.
Yang Z. Preparation and evaluation of rivastigmine liposomes for intranasal delivery BT - liposome-based drug delivery systems. In: Lu W-L, Qi X-R, editors. Berlin. Heidelberg: Springer, Berlin Heidelberg; 2021. p. 325–44.
El-Helaly SN, Elbary AA, Kassem MA, El-Nabarawi MA. Electrosteric stealth Rivastigmine loaded liposomes for brain targeting: preparation, characterization, ex vivo, bio-distribution and in vivo pharmacokinetic studies. Drug Deliv. 2017;24:692–700.
Rotman M, Welling MM, Bunschoten A, de Backer ME, Rip J, Nabuurs RJA, et al. Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer’s disease. J Control Release. 2015;203:40–50.
Krishna KV, Wadhwa G, Alexander A, Kanojia N, Saha RN, Kukreti R, et al. Design and biological evaluation of lipoprotein-based donepezil nanocarrier for enhanced brain uptake through oral delivery. ACS Chem Neurosci. 2019;10:4124–35.
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54.
Yang T, Choi M-K, Cui F-D, Kim JS, Chung S-J, Shim C-K, et al. Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome. J Control Release. 2007;120:169–77.
Krishna KV, Saha RN, Dubey SK. Biophysical, biochemical, and behavioral implications of ApoE3 conjugated donepezil nanomedicine in a Aβ1-42induced Alzheimer’s disease rat model. ACS Chem Neurosci. 2020;11:4139–51.
Bibi S, Kaur R, Henriksen-Lacey M, McNeil SE, Wilkhu J, Lattmann E, et al. Microscopy imaging of liposomes: from coverslips to environmental SEM. Int J Pharm. 2011;417:138–50.
Li T, Nowell CJ, Cipolla D, Rades T, Boyd BJ. Direct comparison of standard transmission electron microscopy and cryogenic-TEM in imaging nanocrystals inside liposomes. Mol Pharm [Internet]. 2019 [cited 2022 Oct 3];16:1775–81. Available from: https://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.8b01308.
Hubin E, Verghese PB, van Nuland N, Broersen K. Apolipoprotein E associated with reconstituted high-density lipoprotein-like particles is protected from aggregation. FEBS Lett [Internet]. 2019 [cited 2022 Oct 3];593:1144–53. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/1873-3468.13428.
Whitmore L, Wallace BA. Protein secondary structure analyses from circular dichroism spectroscopy: methods and reference databases. Biopolymers. 2008;89:392–400.
Mulik RS, Mönkkönen J, Juvonen RO, Mahadik KR, Paradkar AR. ApoE3 mediated polymeric nanoparticles containing curcumin: apoptosis induced in vitro anticancer activity against neuroblastoma cells. Int J Pharm. 2012;437:29–41.
Aleskndrany A, Sahin I. The effects of Levothyroxine on the structure and dynamics of DPPC liposome: FTIR and DSC studies. Biochimica et Biophysica Acta (BBA) - Biomembranes. 2020;1862:183245.
Farooq MA, Xinyu H, Jabeen A, Ahsan A, Seidu TA, Kutoka PT, et al. Enhanced cellular uptake and cytotoxicity of vorinostat through encapsulation in TPGS-modified liposomes. Colloids Surf B Biointerfaces. 2021;199:111523.
Cheng Y, Zou T, Dai M, He XY, Peng N, Wu K, et al. Doxorubicin loaded tumor-triggered targeting ammonium bicarbonate liposomes for tumor-specific drug delivery. Colloids Surf B Biointerfaces. 2019;178:263–8.
Fernandes M, Lopes I, Magalhães L, Sárria MP, Machado R, Sousa JC, et al. Novel concept of exosome-like liposomes for the treatment of Alzheimer’s disease. J Control Release. 2021;336:130–43.
Liu DM, Xu B, Dong C. Recent advances in colorimetric strategies for acetylcholinesterase assay and their applications. TrAC Trends Anal Chem. 2021;142:116320.
ElKady EF, Mostafa EA. Validated LC/MS/MS Method for the determination of rivastigmine in human plasma: application to a pharmacokinetic study in Egyptian volunteers to determine the effect of gender and body mass index. J Chromatogr Sci [Internet]. 2023 [cited 2023 Aug 20];61:453–60. Available from: https://pubmed.ncbi.nlm.nih.gov/35750040/.
Kreuter J. Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? Adv Drug Deliv Rev [Internet]. 2014 [cited 2023 Aug 20];71:2–14. Available from: https://pubmed.ncbi.nlm.nih.gov/23981489/.
Juhairiyah F, de Lange ECM. Understanding drug delivery to the brain using liposome-based strategies: studies that provide mechanistic insights are essential. AAPS J [Internet]. 2021 [cited 2023 Aug 20];23. Available from: https://pmc/articles/PMC8553706/.
Dash S, Murthy P, Nath L, Pharm PC-AP, 2010 undefined. Kinetic modeling on drug release from controlled drug delivery systems. academia.edu [Internet]. [cited 2023 Jul 20]; Available from: https://www.academia.edu/download/61513061/Dash__Murthy_201020191214-52263-1z0h7e0.pdf.